Hubei Xingfa based in Yichang City, China has made a tremendous ascending step by moving out of the Chinese pavilion and that too in its own booth this year at IFT17, The Institute of Food Technologists’ annual meeting and food exposition held in June 25-28th of the year.
It has shifted its headquarters IN Schaumburg, III, and now it has acquired an office triple the size of the earlier office in North America in Naperville, III. The company now owns a two-storey building with almost 650,000 square feet of space. With the new move, the company will support increasing demand for phosphates in the categories of foods and beverages, pharma and nutrition, agriculture, and industrial specialties.
“This recent investment underscores Xingfa’s commitment to our current and prospective customers and is a direct result of the company’s accelerated growth in the U.S.,” said J. Bryan Kitchen, Xingfa’s president of North America.
Mr. J. Bryan was named as the president of North America at the first half of the year, and co-incidentally it was the time the company named Larry Esposito as business vice-president, Food & Beverage, Pharma & Nutrition and Infrastructure for Xingfa. In his new position, Mr. Esposito will be responsible for growing Xingfa’s presence in the North American food and beverage, pharma and nutrition, and infrastructure markets.
“Xingfa’s specialty compounds portfolio combines the key functionalities required for the development of high-quality foods, with a reliable, sustainable, high-quality ingredient supply,” said Mr. Esposito said. “Our vertically integrated operations give us complete control of the supply chain, providing our customers with unmatched reliability, traceability and sustainability.”
Hubei Xingfa is considered one of the largest manufacturers of specialty phosphates in China has been developing and marketing phosphorous-based specialty chemicals to more than 50 countries. The company also offers seafood, meat, bakery, noodles and cheese.
YOU MIGHT ALSO LIKE::
Benchmark Electronics will develop Qualcomm’s biometric patches to monitor vital signs and track patients